Effects of Intracoronary Pro-urokinase or Tirofiban on Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: A Multi-Center, Placebo-Controlled, Single-Blind, Randomized Clinical Trial

Effects of Intracoronary Pro-urokinase or Tirofiban on Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: A Multi-Center, Placebo-Controlled, Single-Blind, Randomized Clinical Trial

Background: To determine whether intracoronary pro-urokinase or tirofiban improves myocardial reperfusion during primary percutaneous coronary intervention (PCI) for acute ST-segment elevation myocardial infarction (STEMI).Methods: The study included patients with acute STEMI presenting within 12 h...

Full description

Bibliographic Details
Main Authors:	Dong Huang, Juying Qian, Zongjun Liu, Yawei Xu, Xianxian Zhao, Zengyong Qiao, Weiyi Fang, Li Jiang, Wei Hu, Chengxing Shen, Chun Liang, Qi Zhang, Junbo Ge
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-08-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	thrombolysis/thrombolytic agents acute myocardial infarction percutaneous coronary intervention glycoprotein IIB/IIIA inhibitors tirofiban myocardial reperfusion
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2021.710994/full

Similar Items

Tirofiban Induced Thrombocytopenia: A Rare but Severe Adverse Effect
by: Muhammad Shabbir Rawala, et al.
Published: (2020-03-01)

Severe thrombocytopenia induced by tirofiban after percutaneous coronary intervention: a case report
by: Ze-Mu Wang, et al.
Published: (2023-10-01)

Safety and Efficacy of Tirofiban in Rescue Treatment for Acute Intracranial Intraprocedural Stent Thrombosis
by: Lili Sun, et al.
Published: (2020-06-01)

Tirofiban-induced thrombocytopenia
by: Jun Wang, et al.
Published: (2023-12-01)

Antiplatelet medications in acute coronary syndromes and percutaneous coronary interventions: focus on tirofiban
by: T. A. Batyraliev, et al.
Published: (2008-12-01)

Comparison between the effect of intracoronary bolus of tirofiban versus eptifibatide as adjunctive antiplatelet therapy on the outcome of primary coronary intervention in patients with acute anterior ST segment elevation myocardial infarction
by: Tarek M. Zaki, et al.
Published: (2011-06-01)

Thrombocytopenia induced by glycoprotein (GP) IIb-IIIa antagonists: about two cases
by: Salma Abdeladim, et al.
Published: (2021-01-01)

Intracoronary versus intravenous glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in patients with STEMI: a systematic review and meta-analysis
by: JongSung Hahn, et al.
Published: (2023-07-01)

Use of glycoprotein IIb/IIIa antagonists to prevent stent thrombosis in morphine-treated patients with ST-elevation myocardial infarction
by: Bastiaan Zwart, et al.
Published: (2020-02-01)

Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease
by: Salam Amar M, et al.
Published: (2001-07-01)

Acute profound thrombocytopenia induced by tirofiban in stent assisted embolization of intracranial ruptured aneurysm-a rare case report
by: Bingda Piao, et al.
Published: (2023-04-01)

Glycoprotein IIb/IIIa Receptor Inhibitors in Patients with ST-Segment Elevation Myocardial Infarction and Primary Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2020-01-01)

Gene mutations of platelet glycoproteins and response to tirofiban in acute coronary syndrome
by: Antonio de Padua Mansur, et al.

Effect of tailored use of tirofiban in patients with Non-ST-elevation acute coronary syndrome undergoing percutaneous coronary intervention: a randomized controlled trial
by: Wonjae Lee, et al.
Published: (2018-10-01)

Phospholipid metabolism and effectiveness of a glycoprotein IIb/IIIa receptor blocker tirofiban in patients with acute coronary syndrome without ST segment elevation
by: Sh. I. Makhamatova, et al.
Published: (2009-12-01)

Safety and efficacy of tirofiban after intravenous thrombolysis with urokinase in patients with acute ischemic stroke
by: Dian Qu, et al.
Published: (2025-03-01)

Safety and Effectiveness of Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
by: Abdul Hafeez Ahmad Hamdi, et al.
Published: (2017-07-01)

Scorpion envenomation-induced acute thrombotic inferior myocardial infarction
by: Ahmet Oytun Baykan, et al.
Published: (2016-02-01)

Identification and Characterization of Glanzmann Thrombasthenia in 2 Closely Related Mixed‐breed Dogs
by: L.Z. Haysom, et al.
Published: (2016-03-01)

Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis
by: Zhe Wang, et al.
Published: (2020-03-01)

Safety and efficacy of IIb/IIIa inhibitors in combination with highly active oral antiplatelet regimens in acute coronary syndromes: A meta-analysis of pivotal trials
by: Vincent Roule, et al.
Published: (2017-02-01)

Prospective pilot study of tirofiban in progressive stroke after intravenous thrombolysis
by: Yan Zhang, et al.
Published: (2022-10-01)

Efficacy and safety of intracoronary versus intravenous tirofiban in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A meta-analysis of randomized controlled trials
by: Rui Tian, et al.
Published: (2023-05-01)

One-Year Safety and Effectiveness of Bivalirudin versus Heparin in Patients Undergoing Elective Percutaneous Coronary Intervention
by: Jiawen Li, et al.
Published: (2023-07-01)

Implications of troponin testing in clinical medicine
by: Meinertz Thomas, et al.
Published: (2001-04-01)

Glycoprotein IIb/IIIa inhibitors for cardiogenic shock complicating acute myocardial infarction: a systematic review, meta-analysis, and meta-regression
by: Carolina Saleiro, et al.
Published: (2020-11-01)

Los inhibidores de los receptores plaquetarios IIb/IIIa en los síndromes coronarios agudos. The IIb/IIIa platelet receptor inhibitors in the acute coronary syndromes.
by: Fidel Manuel Cáceres Lóriga, et al.
Published: (2001-01-01)

Outcome after systemic thrombolysis is predicted by age and stroke severity: an open label experience with recombinant tissue plasminogen activator and tirofiban
by: Rudiger J. Seitz, et al.
Published: (2012-09-01)

Successful management of left main coronary artery thrombus with intracoronary thrombolysis
by: Ufuk Gürkan, et al.
Published: (2014-07-01)

Efficacy and safety of tirofiban in patients with acute ischemic stroke without large-vessel occlusion and not receiving intravenous thrombolysis: A randomized controlled open-label trial
by: Yongpeng Yu, et al.
Published: (2022-12-01)

High bolus tirofiban vs abciximab in acute STEMI patients undergoing primary PCI - The tamip study
by: Mohammed A Balghith
Published: (2012-01-01)

A novel ITGA2B double cytosine frameshift variant (c.1986_1987insCC) leads to Glanzmann's thrombasthenia in a cat
by: Victor N. Rivas, et al.
Published: (2024-05-01)

Ex vivo STUDY OF THE ACTION OF INTEGRIN RECEPTORS ANTAGONIST FROM ECHIS MULTISQUAMATIS SNAKE VENOM ON PLATELETS OF PREGNANT WOMEN WITH COMPICATIONS DURING GESTATION
by: O. M. PLATONOV, et al.
Published: (2023-04-01)

Combination antiplatelet treatment in coronary artery disease patients: A necessary evil or an overzealous practice?
by: Dimitrios Alexopoulos, et al.
Published: (2018-04-01)

Arteriosclerosis and the promise of GPIIb/IIIa inhibitors in stroke Arteriosclerosis y nuevas perspectivas de los inhibidores del receptor GPIIb/IIIa en stroke
by: GUSTAVO SAPOSNIK, et al.
Published: (2000-03-01)

Intracoronary artery retrograde thrombolysis combined with percutaneous coronary interventions for ST-segment elevation myocardial infarction complicated with diabetes mellitus: A case report and literature review
by: Mingzhi Shen, et al.
Published: (2022-07-01)

Prolonged enoxaparin therapy compared with standard-of-care antithrombotic therapy in opiate-treated patients undergoing primary percutaneous coronary intervention
by: Wael Sumaya, et al.
Published: (2021-05-01)

Factors influencing platelet aggregation in patients with acute coronary syndrome
by: A V Mazurov, et al.
Published: (2014-09-01)

Intracoronary artery retrograde thrombolysis for ST-segment elevation myocardial infarction with a tortuous coronary artery: A case report and review of the literature
by: Mingzhi Shen, et al.
Published: (2022-08-01)

CORONARY REPERFUSION IN SENILE PATIENTS WITH ACUTE ST ELEVATION MYOCARDIAL INFARCTION
by: E. V. Vyshlov
Published: (2016-08-01)